
Sofosbuvir - Hepatitis C
You are here : Home > Formulary Search > Sofosbuvir - Hepatitis C
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Tablets
Formulary Status :
Restrictions / Comments :
Important
Requires approval from HCV national team for use
Documents :
NICE Technology Appraisal
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Sofosbuvir
Indication :
Hepatitis C
Group Name :
Keywords :
Hep C, NICE, antiviral
Brand Names Include :
Sovaldi
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Sofosbuvir is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hepatitis C.
- Asunaprevir and daclatasvir
- Beclabuvir
- Daclatasvir
- Dasabuvir
- Elbasvir
- Elbasvir/grazoprevir
- Filibuvir
- Glecaprevir/pibrentasvir
- Nitazoxanide
- Paritaprevir
- Paritaprevir/ritonavir/ombitasvir
- Peginterferon alfa
- Ribavirin
- Setrobuvir
- Sofosbuvir and velpatasvir
- Sofosbuvir, daclatasvir and ribavirin
- Sofosbuvir/velpatasvir/voxilaprevir
Committee Recommendations (1)
Funded by NHS England. Treatment should remain with the specialist (RED) hospital only drug.